肝癌合并肝硬化脾亢行肿瘤联合脾切除28例临床分析

目的探讨肝癌合并肝硬化脾功能亢进患者行原发性肝癌切除联合脾切除的临床疗效。方法对1996．1-2002．12间经我院手术治疗的28例肝癌合并肝硬化脾功能亢进患者的临床资料进行回顾性分析。结果28例患者行原发性肝脏癌肿一期切除联合脾切除，手术基本顺利，无手术死亡；术后脾亢症状基本消失。无严重手术并发症。结论对肝癌合并肝硬化脾功能亢进患者行原发性肝癌切除联合脾切除是安全有效的：加强围手术期处理是提高近期疗效的关键，且病理巨脾的切除对术后远期疗效亦是有益的。

Clinical analysis of 28 patients on hepatectomy combined with splenctomy for primary liver cancer associated with liver cirrhosis and hypersplenism

Objective To investigate the clinical effect of hepatectomy combined with and splenectomy in patients with primary liver canceer(PLC)associated with liver cirrhosis and hypersplenism.Methods From 1996.1 to 2002.12,the clinical data of 28 patients with PLC associated with liver cirrhosis and hypersplenism were analysed retrospecively.Results 28 patients underwent hepatectomy combined with splenectomy and postoperative course was unevenful.The symptoms of hypersplenism were disappeared and no serious complications were occurred after operation. Conclusion It is safe and effective to perform hepatectomy combined with splenectomy in patients with PLC associated with liver cirrhosis and hypersplenism.A careful perioperative management is very important and the pathologic splenomegaly resection is beneficial for short and long-term curative effect.